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Summary 
Dendritic  cells  (DC)  are a subset of leukocytes whose major function is antigen presentation. 
We investigated the phenotype and function of enriched  (95-98.5%)  rat DC. We show that 
both spleen and thymus DC express the natural killer cell receptor protein  1 (NK_R.-P1)  as a 
disulfide linked homodimer of 60 kD.  Freshly isolated DC express a low level of NKtL-P1, 
which is strongly upregulated after overnight culture. Spleen, but not thymus DC, were able to 
kill the NK-sensitive YAC-1 cell line in vitro, and since this killing was Ca  2+ dependent, a Fas 
ligand-Fas  interaction  was  probably  not  involved.  Besides  their  potent  antigen-presenting 
function, DC can thus be cytotoxic for some tumor targets. 
D 
endritic cells (DC) are a specialized class ofleukocytes 
found  in  many  tissues  and  most  abundantly  in  the 
T-dependent  areas  of lymphoid  organs  (1).  They play  a 
fundamental role in antigen presentation to T  cells,  being 
very potent since only small numbers of DC are sufficient 
to  induce  T  cell  responses  (2,  3).  DC  can  prime  naive 
T-cells (CD4 and CDS) both in vitro and in vivo (1). A re- 
cent report suggests that DC may directly modulate B  cell 
growth  and  differentiation  (4).  The  antigen  presenting 
function of DC is related to their high expression of both 
class I and class II MHC products,  as well as different co- 
stimulatory  and  adhesion  molecules  (1).  Moreover,  they 
have special antigen handling mechanisms, including the lec- 
tin-type DEC-205  in  mice  and  the  mannose  receptor  in 
humans (5, 6) and abundant MHC class II rich vacuoles (7). 
In the  absence of known unique  DC markers, these  cells 
are mainly recognized on the basis of their typical dendritic 
morphology and their high expression of class II molecules. 
However, several surface antigens have been found prefer- 
entially  expressed  by  rodent  DC,  such  as  the  integrin 
CDllc  (8), the DEC-205 receptor (6), and a candidate in- 
tegrin recognized by the OX-62 mAb (9). 
The  ontogeny  of DC  remains  controversial  (10);  al- 
though most of these cells seem to have a myeloid origin, 
recent reports indicate that thymus DC are of lymphoid or- 
igin, sharing a common thymic precursor with T  and NK 
cells  (11).  A  common hematopoietic precursor for T,  B, 
NK, and DC has also been described in humans (12)  but, 
to the best of our knowledge, the presence of NK-related 
markers  or  functions  on  differentiated  DC  has  not  been 
previously described. Moreover, different DC subsets have 
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been defined based on their phenotype and, more interest- 
ingly, on their function (13). Thus, murine spleen DC can be 
separated in  two populations  depending  on whether they 
express the CD80t molecule (14). Although CD8- DC ex- 
hibit potent antigen-presenting function, CD8 + cells may in- 
activate mature peripheral CD4 + T  cells using a Fas ligand- 
dependent mechanism (15),  indicating that some DC may 
kill Fas-expressing cells. 
Natural killer cell receptor protein 1 (NKR-P1) is a disul- 
fide-linked homodimer expressed by all NK cells and a small 
subset ofT cells in rodents, and it belongs to the group V of 
the C  type lectin superfamily, which also includes the CD69, 
Ly49, and CD94 molecules (16).  NKP,.-P1 molecules have 
also been described in humans  (16).  Previous studies have 
shown that NKP,.-P1  is an activation receptor on rat NK 
cells, leading to stimulation of granule exocytosis, and anti- 
NKR-P1  mAb  (3.2.3)  can  redirect  lysis  of NK-resistant 
target cells by NK cells  (17-19). Here, we describe that rat 
DC express NKIL-P1. Furthermore, highly purified spleen, 
but not thymus DC exhibit a NK-like cytotoxicity in vitro. 
We suggest that this unusual function of DC could facilitate 
the  phagocytosis  of cell  fragments and  subsequent  antigen 
presentation to T  cells, creating a direct link between innate 
and adaptive immunity. 
Materials and Methods 
Animals.  4--5-wk-old male rats ~om the strains Wistar, Sprague- 
Dawley,  Lewis.lA,  or Lewis were purchased  from the  Centre 
d'Elevage Janvier (Le Genest-Saint-Isle,  France). 
Medium.  The culture  medium used (complete  medium) was 
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with heat-inactivated 10% FCS (Life Technologies, Eragny, France), 
2 m/Vl t-glutamme, 100 U/ml penicillin, 0.1 mg/rnl streptomycin, 1 
mM sodium pyruvate, and 5 ×  10 -5 M  2-mercaptoethanol. 
mAbs.  The following hybridomas (all mouse IgG) were ob- 
tained from  the  European  Collection of Animal Cell  Culture 
(Salisbury, UK): OX6  (class II), OX8  (CD800,  OX39  (CD25), 
R73  (TCR.-ot/[3), OX12  (Ig k chain), ED3 (sialoadhesin),  OX62 
(integrin on  DC),  OX33  (CD45RA),  OX22  (CD45-RC),  and 
341.1  (CD813). V65  (TCR-y/8)  was  provided  by  T.  Hunig 
(7¢urzburg,  Germany). The mAb 3.2.3  (NKR.-P1) was purchased 
from  Serotec  (Oxford,  UK).  The  fusion  molecules CTLA4-1g 
(provided by P.S.  Linsley, Bristol-Myers Squibb,  Seattle, WA) 
recognizing B7-1 and B7-2 and Fas-Ig (provided by F. Go&an, 
Institut National de la Sante et de la Recherche Medicale U373, 
Paris,  France) were  used at 2.5  b~g/ml.  H19-282  mAb  (mouse 
IgG1 anti-human CD59)  was used as negative control for stain- 
ing and in vitro culture studies and was provided by A. Bernard 
(Hopital de l'Archet, Nice,  France). Control mouse IgG2b was 
purchased from PharMingen (San Diego, CA). 
Purification of DC.  Thymus  and  spleen  fragments  were  di- 
gested with 2 mg/rnl collagenase D  (Boehringer-Mannheim, In- 
clianapotis,  IN)  for  15  rain at 37°C  in  the presence of 10  p,M 
EDTA during the last 5 min (14). The cell suspension was washed 
and resuspended in 5 ~M PBS EDTA containing 2% heat-inacti- 
vated FCS at 4°C at 1-2  ×  108 cells/ml. 4 ml of this suspension 
was layered onto 4  ml of 14.5%  (wt/vol) metrizamide (grade I, 
Sigma Chemical Co.) in PBS in 15-ml conical tubes and centri- 
fuged  13 rain at  1,800 g  at 4°C.  Low-density cells were recov- 
ered, washed twice, and resuspended at 107 cells/ml in complete 
medium for culture overnight at 37°C in 5% CO2. Nonadherent 
cells were then further enriched for DC by centrifugation over a 
14.5% metrizamide column, and subjected to two rounds of plas- 
tic adherence for 1 h at 37°C.  Using this method, we routinely 
obtained spleen or thymus cell suspensions containing 60-85 and 
70-90% DC, respectively, as assessed by morphology and pheno- 
type (high level of class II and B7 molecules expression, see Re- 
suits section). A final enrichment for DC was routinely performed 
by removing T  cells,  B  cells,  and macrophages using magnetic 
beads. In brief, cells were incubated with a mixture of appropriate 
dilutions of R7.3, V65, OX12, OX33, OX22, OX8, 341.1, and 
ED3 mAbs for 30 min at 4°C, washed three times, and then incu- 
bated  with  anti-mouse  IgG-coated  Dynabeads  (Dynal,  Oslo, 
Norway) for 20 min at 4°C with agitation. After three rounds of 
magnetic depletion, the final cell populations contained between 
95  and 98.5%  DC. Enriched populations of fresh DC were also 
prepared (as indicated) by selection of low-density cells from col- 
lagenase-digested organs followed by magnetic bead depletion of 
TClL-a/[3 or -y/8,  slg, CD45R,  CD4,  CD8,  and sialoadhesin 
positive cells.  In all cases, the enriched DC lacked CD8 + cells, 
whereas CD8 is an independent marker for rat NK cells (20). 
Immunofluorescence Analysis.  For flow cytometry analysis, 5  X 
104  cells were incubated with mAb for 30 min at 4°C,  washed 
twice with PBS/0.2% BSA/0.1% NaN  3, and then incubated with 
appropriate FITC-conjugated secondary antibody 0ackson Labs., 
West Grove, PA). After three washes, the cells were analyzed on 
a  Facscalibur  ® flow  cytometer  (Becton  Dickinson,  Mountain 
View, CA). Dead cells were excluded from analysis by briefly in- 
cubating the cells with propidium iodide. For two-color immuno- 
fluorescence, 105 cells were incubated with biotinylated OX6 or 
OX62 mAbs and FITC-conjugated 3.2.3, R7.3, or OX8 mAbs, 
followed by streptavidin-PE (Immunotech, Marseille, France). 
Biotinylation of Cell Suface Proteins and Immunopredpitation.  Cells 
were washed, twice in PBS and resuspended at 106/illl in 5 mM 
N-hydroxy succinimide ester-biotin (Sigma Chemical Co.) in bi- 
otinylation buffer (10 mM Na-borate, pH 8.8,  150  mM NaC1), 
incubated for 30 rain at 4°C, washed twice in RPMI  1640,  and 
twice in PBS at 4°C. Cells were then lysed at 2  ×  106/rnl  for 30 
rain on ice in 1% NP-40 lysis buffer containing 20 mM Tris-HC1, 
pH 7.5,  150 mM NaC1,  1 nlM MgC12, and 1 rnNl EGTA in the 
presence of the protease inhibitors 10 btg/ml leupeptin and apro- 
tinin.  Posmuclear  lysates  were  obtained  after  centrifugation 
(14,000 rprn for 15 min at 4°C)  and were precleared for 2 h with 
2  ×  107 goat anti-mouse IgG-coated magnetic beads (Dynal)/rnl 
of lysate prewashed in 1% NP-40 lysis buffer. Lysates were then 
subjected to immunoprecipitation for 2 h with mAbs, and then for 
2 h with 4  ×  107 beads/ml oflysate at 4°C.  Immunoprecipitates 
were washed in 1% detergent lysis buffer and twice in 0.05% de- 
tergent lysis buffer, boiled in sample buffer, and separated on 5-13% 
SDS-PAGE under reducing or nonreducing conditions as indi- 
cated. Immunoblotting and protein detection were performed as 
described (21). 
Cytotoxicity Assays.  Cytotoxic activity of DC populations was 
assessed in  a  standard 6-h 51Cr-release  assay using the YAC-1, 
P815, L12-10, and K562 cell lines as targets. In brief, target cells 
were labeled with Na SlCr for 45 rain at 37°C in complete me- 
dium. Serial dilutions of effector cells in complete medium were 
mixed with 2,000 target cells in V-bottom 96-well plates, centri- 
fuged 3 min at 1,500 g, and incubated for 6 h at 37°C, 5% CO2. 
The supernatants were harvested and specific 5lCr release was de- 
termined as described (22). 
Results and Discussion 
Rat DC Express the NKR-P1 Molecule.  Using  the  pro- 
tocol described in the Materials and Methods  section, we 
routinely obtained spleen and thymus DC populations 95- 
98%  homogeneous.  These  cells exhibit a  typical dendritic 
morphology (data not shown)  and lack of esterase and my- 
eloperoxidase (data not shown), and express very high levels 
of class II and B7 molecules (Fig. 1). They do not express T 
or B  cell receptors, sialoadhesin (Fig. 1), nor CD8  (Fig. 2). 
Moreover, they express high levels of CD25,  and the anti- 
gen recognized by the OX62 mAb was expressed at a low 
to  moderate  level by  a  subset  of spleen  and  thymus  DC 
(Fig.  1).  The complete phenotype and morphological fea- 
tures  of rat  DC  will be  described elsewhere  (our  manu- 
script in preparation). DC  preparations from both thymus 
and spleen had potent stimulatory activity (>300-fold su- 
perior  to  total  spleen  cells)  in  primary  allogeneic  mixed 
leukocyte culture  (data not  shown).  Of particular interest 
was  that  >90%  of spleen  and  thymus  DC  expressed  the 
NKR-P1  molecule recognized by the 3.2.3  mAb  (Fig.  1). 
DC  expression of NKIL-P1  was not strain-restricted since 
we have observed similar staining for this molecule on DC 
isolated from  Lewis, Wistar, and  Sprague-Dawley rats.  In 
contrast, spleen DC from the C57B1/6 mouse strain do not 
express the NKR-P1C  molecule (23). 
Upregulation  of NKR-P1  Expression  on DC  upon In  Vitro 
Culture.  The  expression  of  NKR-P1  was  assessed  on 
freshly extracted  DC  before  culturing  at  370C,  which  is 
known  to  result  in  DC  activation  (1).  Low-density  cells 
were  depleted of non-DC  after treatment with mAbs and 
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Figure  1.  The  phenotype  of 
thymus and spleen rat DC. DC 
were purified as described in the 
Materials and  Methods  section. 
Expression of the indicated anti- 
gens was analyzed in single color 
immunofluorescence.  Propid- 
mm iodide was used to exclude 
dead cells from analysis. Dotted 
lines show the background with 
isotype-matched  control  anti- 
body.  Each  staining was  per- 
formed  at  least six  times  with 
similar results. 
magnetic  beads.  Expression  of NKR-P1  was  assessed  on 
both OX62-positive or oX6hig  h cells in two-color immu- 
no  fluorescence (Fig. 2). Low level expression was observed 
on spleen DC, and was strongly upregulated after overnight 
culture.  Similar results were obtained on individual OX6~g  h 
or  OX62-positive  (gated)  populations  and  with  thymus 
DC  (data not shown). As expected, we did not observe de 
novo expression of TCR  or CD8  (Fig. 2). The finding that 
after  overnight  culture,  the  expression  of NKI1.-P1A was 
upregulated on DC excluded the possibility that the NKR- 
P1  molecule  was  adsorbed  rather  than  synthesized.  The 
overnight  culture  step  currently used  during  the  purifica- 
tion of rodent DC is thought to reproduce their in vivo ac- 
tivation  (1).  Thus,  although  it remains  to  be  shown,  it is 
likely that upregulation of NKR-P1  also occurs in vivo. 
Immunoprecipitation  of the  Molecule Recognized by  3.2.3 
mAb on Rat DC.  The  molecule recognized by the  3.2.3 
mAb  on  rat  spleen  DC  was  immunoprecipitated  from 
highly purified (>97%)  DC preparations and NK-enriched 
populations (nylon wool nonadherent spleen cells) and ana- 
lyzed on SDS-PAGE gel (Fig. 3). As expected (17),  a mole- 
cule of"60  kD recognized by 3.2.3 mAb appeared composed 
of two  homodimeric  chains  of "~30  kD  on  NK-enriched 
spleen cell populations. The  NKR-P1  molecule from DC 
Fresh  After  culture  Figure  2.  Upregulation  of 
k  NKR-P1  expression  on  DC 
Te.R  upon overnight in vitro culture. 
Enriched  populations  of  fresh 
DC  were  prepared by selecting 
low-density cells of collagenase- 
I~(11-I'1  -  digested spleen and thymus fol- 
lowed by magnetic beads deple- 
tion  of non-DC.  An aliquot of 
the  cells was  then  analyzed in 
k  two-color  immunofluorescence 
Cl)~  with  biotynylated  OX6  or 
OX62 mAbs followed by FITC- 
1  ~  3  1  2  a  conjugated 11.7.3, 3.2.3, OX8, or 
Lov0fl.o  control mAb  and  streptavidin- 
PE.  The  remaining  cells were 
cultured overnight in complete P,.PMI and analyzed as described above. 
The histograms show expression patterns of TCR, NKI1.-P1, and CD8 
on OX62-positive gated cells. Dotted lines show the background with 
isotype-matched control antibodies. The results are representative  Of four 
different experiments. 
resolved  under  reducing  conditions  into  two  bands,  the 
major  one  corresponding to  "-'30  kD,  as  expected,  and  a 
second one migrating slightly slower than  the nonreduced 
molecule of~60  kD. The persistence of this band could be 
due  to  incomplete reduction,  possibly reflecting a  greater 
aggregate-forming tendency of the NKR-P1  monomers on 
DC compared to those expressed on NK cells. 
In Vitro Cytotoxicity of Rat DC.  Based  on  our  results 
that showed that rat DC expressed a NK-related molecule, 
we tested in 6-h Cr release assays the potential cytolytic ac- 
tivity of highly purified DC on target cells usually used for 
testing NK  activity. As shown  in  Fig.  4,  spleen DC  effi- 
ciently killed the  prototypical NK-sensitive YAC-1  cells. 
The level of killing observed was roughly similar to that re- 
ported with the rat NK cell line P,.NK-16 at the same E/T 
ratios  (19).  This  unusual  activity was  also  observed  using 
spleen DC maintained in culture for >3 d  (data not shown) 
and was reproduced in >  10 independent experiments. The 
possibility that  our  DC  preparations  contained  NK  cells 
was excluded because the only non-DC  contaminating our 
DC preparations (95-98.5% pure) corresponded to CD45- 
cells (fibroblasts, endothelial cells) and because  our proce- 
dure included a  depletion of CD8 +  cells (20).  Even if the 
contaminating  cells  were  NK,  it  does  not  seem  possible 
that they could be responsible for the lysis of YAC cells we 
observed as total spleen cells from the same animal, which 
contain  15-25%  NK  cells,  exhibited  an  anti-YAC  cyto- 
toxic activity lower than  that found for spleen DC  at  the 
same E/T  ratios  (Fig. 4).  As compared to YAC-1  targets, 
Figure  3.  lmmtmoprecipitation 
of membrane NKR-P1.  Immu- 
noprecipitation  was  performed 
on  spleen DC  (97%) and  NK- 
enriched  populations  (nylon 
wool nonadherent spleen cells)  as 
described in Materials and Meth- 
ods. Samples were loaded on 5- 
13%  SDS-PAGE  and  analyzed 
by immunoblotting  and chemi- 
luminescence. Lanes I and 2, NK- 
enriched spleen cells; lanes 3 and 
4, spleen DC; lanes 1 and 3, non- 
reduced; lanes 2 and 4, reduced. 
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Figure  4.  In vitro cytolytic activity of spleen and thymus DC against 
YAC-1 and P815.2 ×  103 51Cr-labeled YAC-1 (le~) or P815 (right) tar- 
get cells were incubated with total spleen cells (open circle), purified (95- 
98.5) spleen (closed square),  or thymus (open square) DC in triplicate for 6 h 
at 37°C. 51Cr release was then assessed in the supernatant. Results of one 
experiment representative of  at least eight for each target are shown. 
the  cytotoxic activity of spleen  DC  against P815  (Fig.  4), 
L12.10, or K562 (data not shown) was low. 
Despite  a  very similar  phenotype  compared  to  splenic 
DC,  those  isolated  from thymus  exhibited  a  very low  in 
vitro killing  activity  (Fig.  4).  It is possible  that  the  spleen 
DC population is heterogenous and that the cytolytic func- 
tion that we observed was dependent on a specialized sub- 
population not related to thymus DC. Indeed, at least some 
markers such as OX62  (Fig.  1),  CD5, or OX41  mAb (our 
manuscript  in  preparation)  seem  to  define  subsets  of rat 
DC. Alternatively, this discrepancy could be related to dif- 
ferent  maturation  stages between  thymus  and  spleen  DC. 
The ability of the different types of DC to kill other target 
cells in longer assays, or the same targets after cytokine acti- 
vation, is under investigation. 
Two arguments indicated that rat spleen DC probably do 
not kill YAC-1 target cells through the FasL/Fas pathway. 
First,  we  could not  detect  membrane  FasL expression  on 
spleen  or thymus  DC,  as  determined  by  FACS  ® using  a 
Fas-lg chimeric molecule (data not shown). Second, the in 
vitro  cytolytic activity of splenic DC was abrogated upon 
addition of EGTA (2 raM)  to the culture,  together with 
2  mM MgC12 to ensure  excess  Mg  2+  concentrations  (Fig. 
5).  The  viability  of spleen  DC  during  the  assay  was  not 
modified  by  the  presence  of EGTA  (data  not  shown). 
These  results  indicated  that  the  mechanism  of spleen  DC 
killing was Ca  2÷ dependent, and thus unlikely to be related 
to FasL/Fas interaction  (24).  This contrasts with the recent 
report of Stiss and Shortman showing that a subset of spleen 
DC in mice express a functional Fas hgand molecule  (15). 
It is  unlikely  that  the  complete  inhibition  of splenic  DC 
killing by the chelating agent EGTA was related to the in- 
hibition  of the ligand binding capacity of NKR-P1  mole- 
cule  because  EGTA  concentration  used  in  our  assays  (2 
raM)  is  not  sufficient  to  inhibit  its  carbohydrate-binding 
capacity (25).  The dependence  on Ca  2+ of rat splenic DC 
killing rather suggests a mechanism of granule exocytosis as 
described for CTL and  NK cells.  Whether  rat spleen  DC 
contain perforin-containing granules is under investigation. 
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Figure  5.  Spleen DC kill the 
YAC-1 target cells using a Ca  2+- 
dependent  mechanism.  51Cr- 
labeled YAC-1 target cells (2 × 
103  ) were incubated with puri- 
fied  spleen DC  (95-98.5%) in 
triplicate for 6 h at 37°C in the 
presence  (open  square)  or  ab- 
sence  (closed  square)  of 2  mM 
EGTA and 2 mM MgCI2. SlCr 
release was then assessed in the 
supernatant. Results of one ex- 
periment representative of eight 
are shown. 
To determine whether the NKR-P1 molecule on spleen 
DC is involved in the  killing mechanism of YAC-1  cells, 
we  performed  studies  in  which  3.2.3  mAb  was  preincu- 
bated with DC or added to the assay medium.  No signifi- 
cant  changes were  observed in  the  lysis  of target YAC-1 
cells by purified DC. However, the 3.2.3 mAb was able to 
significantly  redirect  lysis  of P815  target  cells  by  splenic 
DC, since the killing was increased approximately twofold 
as  compared  to  that  in  the  presence  of control  isotype- 
matched mAb  (data not shown).  Ligation of NKR-P1  on 
NK cells  initiates  a  transmembrane  signal that mimics  the 
response of these cells to target cells (16), stimulates granule 
exocytosis and mediates redirected lysis of NK-resistant tar- 
get cells  (17).  Our results also suggest that NKR-P1  could 
also activate cytotoxic mechanisms of DC. Moreover, pre- 
liminary  results  indicate  that hgation  of NKR.-P1  on DC 
during allogeneic  mixed leukocyte  culture  could substan- 
tially increase  the proliferative response of T  cells.  The hy- 
pothesis that this stimulatory function of NKR-P1 is due to 
the production of a soluble factor by DC is consistent with 
the fact that NKR-P1  cross-hnking on mouse NK cells in- 
duces  not  only  cytotoxicity  but  also  IFN-',/  production 
(26). As recently demonstrated for other important C-type 
lectin  receptors  present  on DC such as DEC-205  (6)  and 
the mannose receptor  (5),  NKR-P1  could also play a role 
in  receptor-mediated  endocytosis  and  thus  enhance  anti- 
gen-presenting function of DC to syngeneic T  cells. 
It has been  reported  that DC  can infiltrate  primary tu- 
mors in experimental animals and humans and cause tumor 
regression (27). In light of the results presented here, it may 
be  possible  that  this  effect  depends  on a  Ca2+-dependent 
NK-like  cytotoxic function of DC similar  to that we ob- 
served in vitro.  Destruction  of tumoral target cells by DC 
could then facilitate the phagocytosis of cell fragments and 
the presentation ofpeptides from tumor-associated antigens 
to T  cells,  leading to efficient T  cell responses against the 
tumor. 
Of interest,  Fossum and Rolstad  have  shown  that after 
intravenous injection of allogeneic lymphocytes, large frag- 
ments  of these  cells  were  found  inside  interstitial  DC  of 
secondary  lymphoid  organs  (28).  These  authors  rifled  to 
demonstrate  NK  activity,  as  determined  by lysis  of K562 
target cells,  with enriched population of DC collected from 
the thoracic duct, and concluded that NK cells are required 
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by DC. However, although the NK-like cytotoxic activity 
of our DC  preparations was  easily observed with YAC-1 
target cells, the killing ofK562  (data not shown) target cells 
was extremely low, and only spleen but not thymus exhib- 
ited  this  activity. Whether  rat  splenic DC  kill allogeneic 
cells in vitro and in vivo and whether they express killer in- 
hibitory receptors for specific class I molecule (29) is under 
investigation. 
In conclusion, we showed in this study that rat DC  ex- 
hibited both a NK-like phenotype and function. Together 
with the potent antigen processing and presenting function 
of DC,  their ability to kill some target cells could create a 
direct link between  innate  and  adaptive immunity.  It re- 
mains  to  be  determined  whether  this  function  occurs  in 
vivo and whether it is restricted to the rat or is also present 
in mice and humans. 
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